I never consciously swore off health care, but who likes feeling dismissed—or consistently being told that the next available ...
Growth in the brewing enzymes market is attributed to the rising demand for beer and alcoholic drinks, which has led to ...
AstraZeneca's IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...
Based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo AstraZeneca's IMFINZI (durvalumab) has been approved in the US for the treatment of adult ...